Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Frostbite D005627 1 associated lipids
Strongyle Infections, Equine D013319 1 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Edema, Cardiac D004489 1 associated lipids
Osteoblastoma D018215 1 associated lipids
Radiculopathy D011843 1 associated lipids
Oligomenorrhea D009839 1 associated lipids
Erythromelalgia D004916 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Bluetongue D001819 1 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Gastric Dilatation D013271 1 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Stomach Volvulus D013277 1 associated lipids
Foot Rot D005535 1 associated lipids
Aortic Arch Syndromes D001015 2 associated lipids
Mixed Connective Tissue Disease D008947 2 associated lipids
Tachycardia, Paroxysmal D013614 2 associated lipids
Fibromuscular Dysplasia D005352 2 associated lipids
Heart Septal Defects D006343 2 associated lipids
Retinal Vein Occlusion D012170 2 associated lipids
Weil Disease D014895 2 associated lipids
Pulmonary Heart Disease D011660 2 associated lipids
Drowning D004332 2 associated lipids
Pneumonia, Viral D011024 3 associated lipids
Jejunal Diseases D007579 3 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Tachycardia, Supraventricular D013617 3 associated lipids
Pneumonia, Aspiration D011015 3 associated lipids
Infertility D007246 3 associated lipids
Hydatidiform Mole D006828 3 associated lipids
Macular Edema D008269 3 associated lipids
Hemorrhagic Fever with Renal Syndrome D006480 3 associated lipids
Yang Deficiency D016711 3 associated lipids
Contusions D003288 3 associated lipids
Aortic Rupture D001019 3 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Airway Remodeling D056151 3 associated lipids
Angina Pectoris, Variant D000788 3 associated lipids
Chediak-Higashi Syndrome D002609 4 associated lipids
Chest Pain D002637 4 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Streptococcal Infections D013290 4 associated lipids
Retinal Diseases D012164 4 associated lipids
Leiomyosarcoma D007890 4 associated lipids
Thromboangiitis Obliterans D013919 4 associated lipids
Embolism, Fat D004620 4 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Thrombasthenia D013915 4 associated lipids
Menorrhagia D008595 4 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Diseases in Twins D004200 4 associated lipids
Hyperaldosteronism D006929 4 associated lipids
Glomerulosclerosis, Focal Segmental D005923 4 associated lipids
Pulmonary Embolism D011655 5 associated lipids
beta-Thalassemia D017086 5 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Ductus Arteriosus, Patent D004374 5 associated lipids
Placenta Diseases D010922 5 associated lipids
Intracranial Embolism and Thrombosis D002542 5 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Facial Pain D005157 5 associated lipids
Abortion, Habitual D000026 5 associated lipids
Mastocytosis D008415 5 associated lipids
Bartter Syndrome D001477 5 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Hypercapnia D006935 5 associated lipids
Asthenia D001247 5 associated lipids
Respiration Disorders D012120 5 associated lipids
Purpura, Schoenlein-Henoch D011695 5 associated lipids
Sclerosis D012598 5 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Coronary Stenosis D023921 6 associated lipids
Sneezing D012912 6 associated lipids
Bronchitis D001991 6 associated lipids
Intermittent Claudication D007383 6 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Thromboembolism D013923 6 associated lipids
Thrombophilia D019851 6 associated lipids
Periapical Periodontitis D010485 6 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Varicose Veins D014648 7 associated lipids
Behcet Syndrome D001528 7 associated lipids
Agranulocytosis D000380 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Femoral Fractures D005264 7 associated lipids
Bronchopneumonia D001996 7 associated lipids
Raynaud Disease D011928 7 associated lipids
Tachycardia D013610 7 associated lipids
Dyslipidemias D050171 7 associated lipids
Keratitis D007634 7 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Renal Artery Obstruction D012078 8 associated lipids
Enteritis D004751 8 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Simmons PM et al. The release of leukotriene B4 during experimental inflammation. 1983 Biochem. Pharmacol. pmid:6305369
Klosterhalfen B et al. Time course of various inflammatory mediators during recurrent endotoxemia. 1992 Biochem. Pharmacol. pmid:1599496
Stenson WF and Lobos E Inhibition of platelet thromboxane synthetase by sulfasalazine. 1983 Biochem. Pharmacol. pmid:6135423
Chang J et al. Effects of thiazinamium chloride, promethazine and chlorpromazine on thromboxane B2 synthesis, phagocytosis and respiratory burst by rat alveolar macrophages. 1983 Biochem. Pharmacol. pmid:6138040
Deckmyn H et al. Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatrom. 1983 Biochem. Pharmacol. pmid:6578796
Llopis J et al. Eicosanoids released following inhibition of the endoplasmic reticulum Ca2+ pump stimulate Ca2+ efflux in the perfused rat liver. 1993 Biochem. Pharmacol. pmid:8390834
Krämer HJ et al. Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. 1996 Biochem. Pharmacol. pmid:8937428
Patscheke H Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid. 1985 Biochem. Pharmacol. pmid:3922373
Segarnick DJ et al. Precursor- and pool-dependent differential effects of ethanol on human platelet prostanoid synthesis. 1985 Biochem. Pharmacol. pmid:3922375
Satoh K et al. Effects of sulfonylurea agents on platelet arachidonic acid metabolism; study on platelet homogenates. 1994 Biochem. Pharmacol. pmid:8093094
Vanderhoek JY et al. Inhibitory potencies of fish oil hydroxy fatty acids on cellular lipoxygenases and platelet aggregation. 1991 Biochem. Pharmacol. pmid:1831021
Cerletti C et al. Requirement of ADP for arachidonic acid-induced platelet aggregation: studies with selective thromboxane-synthase inhibitors. 1986 Biochem. Pharmacol. pmid:3083818
Bakhle YS and Grantham CJ Selective effect of pulmonary oedema on prostaglandin E2 pharmacokinetics in rat lung. 1985 Biochem. Pharmacol. pmid:3935117
Kanda N and Watanabe S Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes. 2006 Biochem. Pharmacol. pmid:16784723
Klosterhalfen B et al. Influence of heat shock protein 70 and metallothionein induction by zinc-bis-(DL-hydrogenaspartate) on the release of inflammatory mediators in a porcine model of recurrent endotoxemia. 1996 Biochem. Pharmacol. pmid:8937427
Chang WC et al. Inhibition of thromboxane B2 and 6-ketoprostaglandin F1 alpha formation by anti-inflammatory drugs in carrageenin-induced granuloma. 1978 Biochem. Pharmacol. pmid:619892
Yu SM et al. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets. 1992 Biochem. Pharmacol. pmid:1310852
Spaethe SM et al. Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-lipoxygenase inhibitors. 1992 Biochem. Pharmacol. pmid:1310855
Tolman EL and Fuller BL Inhibition of thromboxane synthesis in guinea pig lung and human platelets by clotrimazole and other imidazole antifungals. 1983 Biochem. Pharmacol. pmid:6316985
Oishi K and Yamaguchi M Regulatory effect of arachidonic acid on the calcium transport system in rat liver nuclei. 1993 Biochem. Pharmacol. pmid:8385946
Medini L et al. Diets rich in n-9, n-6 and n-3 fatty acids differentially affect the generation of inositol phosphates and of thromboxane by stimulated platelets, in the rabbit. 1990 Biochem. Pharmacol. pmid:2105092
Faili A et al. Reduction by arachidonic acid of prostaglandin I2-induced cyclic AMP formation. Involvement of prostaglandins E2 and F2 alpha. 1993 Biochem. Pharmacol. pmid:8388209
Huang TF et al. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist. 1991 Biochem. Pharmacol. pmid:1888330
Salmon JA et al. Benoxaprofen does not inhibit formation of leukotriene B4 in a model of acute inflammation. 1984 Biochem. Pharmacol. pmid:6089840
Gresele P et al. L-652,343, a novel dual cyclo/lipoxygenase inhibitor, inhibits LTB4-production by stimulated human polymorphonuclear cells but not by stimulated human whole blood. 1987 Biochem. Pharmacol. pmid:2823826
De La Cruz JP et al. Effects of S-adenosyl-L-methionine on platelet thromboxane and vascular prostacyclin. 1997 Biochem. Pharmacol. pmid:9264331
Maynard PM et al. Effect of glutathione depletion on tissue and plasma prostacyclin and thromboxane in rats. 1992 Biochem. Pharmacol. pmid:1554377
de Gaetano G et al. Low dose aspirin does not prevent fibrinolytic response to venous occlusion. 1986 Biochem. Pharmacol. pmid:3755907
Bauer J et al. Arzanol, a prenylated heterodimeric phloroglucinyl pyrone, inhibits eicosanoid biosynthesis and exhibits anti-inflammatory efficacy in vivo. 2011 Biochem. Pharmacol. pmid:20933508
Gairola CG and Tai HH Cigarette smoke-induced alterations in the release of arachidonate metabolites by pulmonary alveolar macrophage from selenium-fed and selenium-deficient rats. 1986 Biochem. Pharmacol. pmid:3015150
Lloret S and Moreno JJ In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins. 1992 Biochem. Pharmacol. pmid:1417964
Chou TC et al. Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process. 1999 Biochem. Pharmacol. pmid:10535758
Rajtar G et al. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. 1985 Biochem. Pharmacol. pmid:3918536
Williamson EM et al. Studies on the mechanism of action of 12-deoxyphorbolphenylacetate, a potent platelet aggregating tigliane ester. 1981 Biochem. Pharmacol. pmid:6794576
Lorenz RL et al. Effects on prostanoid formation and pharmacokinetics of dazmegrel (UK-38,485), a novel thromboxane synthase inhibitor, in man. 1986 Biochem. Pharmacol. pmid:3513767
Suntres ZE and Shek PN Prophylaxis against lipopolysaccharide-induced lung injuries by liposome-entrapped dexamethasone in rats. 2000 Biochem. Pharmacol. pmid:10704946
Matsuoka I et al. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets. 1989 Biochem. Pharmacol. pmid:2544181
Palmer RM and Salmon JA Comparison of the effects of some compounds on human neutrophil degranulation and leukotriene B4 and thromboxane B2 synthesis. 1985 Biochem. Pharmacol. pmid:2986647
Alanko J et al. Catechol estrogens as inhibitors of leukotriene synthesis. 1998 Biochem. Pharmacol. pmid:9413936
Lynch TJ et al. Carbon tetrachloride-induced eicosanoid synthesis and enzyme release from rat peritoneal leucocytes. 1985 Biochem. Pharmacol. pmid:2986650
Rothberg KG and Hitchcock M In vitro biosynthesis of cyclooxygenase metabolites in ovalbumin-sensitized and control lungs of guinea pigs. 1982 Biochem. Pharmacol. pmid:6812589
Joseph S and MacDermot J Stimulation of U937 human monocytic cells by thrombin results in inositol trisphosphate formation and the mobilisation of intracellular Ca2+ but not the synthesis of thromboxane B2. 1991 Biochem. Soc. Trans. pmid:1889682
Bone EA et al. The effects of strontium and calcium ions on 5-hydroxytryptamine secretion and thromboxane B2 biosynthesis in washed human platelets. 1980 Biochem. Soc. Trans. pmid:7450206
Mitchell MD Prostaglandins at parturition and in the neonatal infant. 1980 Biochem. Soc. Trans. pmid:7450282
Taylor L et al. Prostaglandin production by type II alveolar epithelial cells. 1979 Biochim. Biophys. Acta pmid:435506
Shaw JO et al. Activation of rabbit platelet phospholipase and thromboxane synthesis by 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor). 1981 Biochim. Biophys. Acta pmid:7213765
Powell WS Metabolism of prostaglandins, prostaglandin analogs and thromboxane B2 by lung and liver microsomes from pregnant rabbits. 1979 Biochim. Biophys. Acta pmid:518891
Wahle KW and Peacock LI Effects of isomeric cis and trans eighteen carbon monounsaturated fatty acids on porcine platelet function. 1996 Biochim. Biophys. Acta pmid:8652649
Teng CM et al. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom. 1984 Biochim. Biophys. Acta pmid:6426517
Kimura Y et al. Effects of stilbenes on arachidonate metabolism in leukocytes. 1985 Biochim. Biophys. Acta pmid:3922423
Bellan JA et al. Concentration-activity profile of the modulation of cyclooxygenase product formation by reduced glutathione in microsomal fractions from the goat lung. 1990 Biochim. Biophys. Acta pmid:2114178
Fischer S et al. Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites. 1986 Biochim. Biophys. Acta pmid:3754157
Shaw JO and Lyons RM Requirement for different Ca2+ pools in the activation of rabbit platelets II. Phospholipase activity. 1982 Biochim. Biophys. Acta pmid:6800410
Bartolini G et al. Regulation of thromboxane A2 biosynthesis in platelet-free human monocytes and the possible role of polypeptide growth factor(s) in the induction of cyclooxygenase system. 1986 Biochim. Biophys. Acta pmid:3085720
Grundfest CC et al. Acrolein: a potent modulator of lung macrophage arachidonic acid metabolism. 1982 Biochim. Biophys. Acta pmid:6814492
Aharony D et al. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid. 1982 Biochim. Biophys. Acta pmid:6814496
Croft KD et al. Dietary modification of fatty acid and prostaglandin synthesis in the rat. Effect of variations in the level of dietary fat. 1984 Biochim. Biophys. Acta pmid:6548159
Blackwell GJ et al. Prostacyclin prolongs viability of washed human platelets. 1982 Biochim. Biophys. Acta pmid:6291622
Cathcart MC et al. Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer. 2014 Biochim. Biophys. Acta pmid:24480048
Geisel J et al. Endotoxin-induced arachidonic acid metabolism requires de novo protein synthesis and protein kinase C activation. 1991 Biochim. Biophys. Acta pmid:1909897
Du JT et al. Sex differences in arachidonate cyclo-oxygenase products in elicited rat peritoneal macrophages. 1984 Biochim. Biophys. Acta pmid:6428458
Cook-Johnson RJ et al. Endothelial cell COX-2 expression and activity in hypoxia. 2006 Biochim. Biophys. Acta pmid:17046322
Busshardt E et al. Regulation of hepatic parenchymal and non-parenchymal cell function by the diadenine nucleotides Ap3A and Ap4A. 1989 Biochim. Biophys. Acta pmid:2563228
Honda A et al. Appearance of the arachidonic acid metabolic pathway in human promyelocytic leukemia (HL-60) cells during monocytic differentiation: enhancement of thromboxane synthesis by 1 alpha,25-dihydroxyvitamin D-3. 1986 Biochim. Biophys. Acta pmid:3089289
Sekiya K and Okuda H Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets. 1984 Biochim. Biophys. Acta pmid:6320905
Heemskerk JW et al. Influence of dietary fatty acids on membrane fluidity and activation of rat platelets. 1989 Biochim. Biophys. Acta pmid:2752022
Ciabattoni G et al. Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man. 1989 Biochim. Biophys. Acta pmid:2752040
Patrignani P et al. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey. 1989 Biochim. Biophys. Acta pmid:2752041
Malemud CJ et al. Prostaglandin biosynthesis by lapine articular chondrocytes in culture. 1981 Biochim. Biophys. Acta pmid:6894251
Roberts LJ et al. Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. 1979 Biochim. Biophys. Acta pmid:389290
Fitzpatrick FA and Gorman RR A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors. 1978 Biochim. Biophys. Acta pmid:629996
Bishai I and Coceani F Transformations of prostaglandin H2 in the cat brain. 1981 Biochim. Biophys. Acta pmid:6894549
Orlandi M et al. Thromboxane A2 synthase activity in platelet free human monocytes. 1994 Biochim. Biophys. Acta pmid:7811713
Truitt A et al. Antiplatelet effects of conjugated linoleic acid isomers. 1999 Biochim. Biophys. Acta pmid:10320806
Huang TF et al. Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom. 1987 Biochim. Biophys. Acta pmid:3620499
de Waart DR et al. Studies on the urinary excretion of thromboxane B2 in Zellweger patients and control subjects: evidence for a major role for peroxisomes in the beta-oxidative chain-shortening of thromboxane B2. 1994 Biochim. Biophys. Acta pmid:8155738
Sato T et al. Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated process. 1987 Biochim. Biophys. Acta pmid:3663714
Gorman RR et al. Independence of the cyclic AMP-lowering activity of thromboxane A2 from the platelet release reaction. 1979 Biochim. Biophys. Acta pmid:216409
Fitzpatrick FA and Gorman RR Regulatory role of cyclic adenosine 3',5'-monophosphate on the platelet cyclooxygenase and platelet function. 1979 Biochim. Biophys. Acta pmid:216415
Fuse I and Tai HH Does protein kinase C activation mediate thrombin-induced arachidonate release in human platelets? 1988 Biochim. Biophys. Acta pmid:3140902
Murphy CT et al. Comparison of the role of protein kinase C in platelet functional responses induced by three different mechanisms, PAF, ionomycin and arachidonic acid. 1991 Biochim. Biophys. Acta pmid:1661165
Surya II et al. Enhancement of platelet functions by low density lipoproteins. 1992 Biochim. Biophys. Acta pmid:1420343
Huang TF et al. Antiplatelet protease, kistomin, selectively cleaves human platelet glycoprotein Ib. 1993 Biochim. Biophys. Acta pmid:8251530
Robinson C and Hoult JR Thromboxane A2 analogues inhibit the metabolism of thromboxane B2 in perfused guinea-pig lung. 1983 Biochim. Biophys. Acta pmid:6652102
Teng CM et al. Antiplatelet effect of butylidenephthalide. 1987 Biochim. Biophys. Acta pmid:3109495
Ko FN et al. Antiplatelet effects of chelerythrine chloride isolated from Zanthoxylum simulans. 1990 Biochim. Biophys. Acta pmid:2162213
Tsunomori M et al. 15-Hydroperoxyeicosapentaenoic acid inhibits arachidonic acid metabolism in rabbit platelets more potently than eicosapentaenoic acid. 1996 Biochim. Biophys. Acta pmid:8679681
Ko FN et al. Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchroma. 1995 Biochim. Biophys. Acta pmid:7548232
Mobley A et al. Selective inhibition of 5-lipoxygenase pathway in rat pulmonary alveolar macrophages by cigarette smoking. 1987 Biochim. Biophys. Acta pmid:3030439
Simon MF et al. Selective inhibition of human platelet phospholipase A2 by buffering cytoplasmic calcium with the fluorescent indicator quin 2. Evidence for different calcium sensitivities of phospholipases A2 and C. 1986 Biochim. Biophys. Acta pmid:3080024
Miller OV et al. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence. 1982 Biochim. Biophys. Acta pmid:6285985
Ko FN et al. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies. 1993 Biochim. Biophys. Acta pmid:8380343
Hayashi Y et al. Enzyme immunoassay of thromboxane B2. 1983 Biochim. Biophys. Acta pmid:6407530
Chiabrando C et al. Metabolism of thromboxane B2 in the isolated perfused rat kidney: mass spectrometric identification of urinary products. 1989 Biochim. Biophys. Acta pmid:2597664
Nieuwenhuys CM and Hornstra G The effects of purified eicosapentaenoic and docosahexaenoic acids on arterial thrombosis tendency and platelet function in rats. 1998 Biochim. Biophys. Acta pmid:9487152
Lorenz RL et al. A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator. 1989 Biochim. Biophys. Acta pmid:2597697
Elliott GR et al. Changes in resident rat peritoneal macrophage eicosanoid release, induced by altering the buffer K+/Na+ ratio, are Ca2+ dependent. 1985 Biochim. Biophys. Acta pmid:3933563
Turk J et al. Arachidonic acid metabolism in isolated pancreatic islets. I. Identification and quantitation of lipoxygenase and cyclooxygenase products. 1984 Biochim. Biophys. Acta pmid:6329307
Robinson C et al. Thromboxane B2 uptake and metabolism in isolated perfused lung. Identification and comparison with prostaglandin F2 alpha. 1982 Biochim. Biophys. Acta pmid:6751406
Schafer AI et al. Platelet lipoxygenase-dependent oxygen burst. Evidence for differential activation of lipoxygenase in intact and disrupted human platelets. 1982 Biochim. Biophys. Acta pmid:6812645